Home > Products > CD3 & VEGFR2
> Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv4-Ig)
Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-109)
Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CD3 scFv is fused to the CH1 domain of a heavy chain and another anti-VEGFR2 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Non-small cell lung cancer (NSCLC); Glioblastoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-VEGFR2 Bispecific Antibody (scFv4-Ig) (FVTIG-109). Click the button below to contact us or submit your feedback about this product.